HEALTH● LOWJul 23 · Jul 23, 2026, 11:23 AM
Lenacapavir will slow HIV infections if there's enough of it and it reaches at-risk groups
DW News [en]
Lenacapavir is one injection, twice a year. It's a big improvement for people in high-risk groups, currently taking a pill a day against HIV infection. But its long-term impact depends on it reaching those very people.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH21m agoAMDO Strike: Medical activities partially paralysed in OyoVanguard NigeriaHEALTH27m agoOpen enrollment begins: What Medicare beneficiaries need to know for 2027The HillHEALTH28m agoOzempic users may face protein, vitamin D deficiencies, experts warnThe HillHEALTH29m agoJ&J reports 75% tumor response rate with novel prostate cancer therapySeeking Alpha Tech